Drug
14c Bgb 11417
14c Bgb 11417: highest development phase Phase 1, developed by BeiGene. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BeiGene
Trials
| Drug | Phase | Indication |
|---|---|---|
| [14C]-BGB-11417 NCT05844111 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow 14c Bgb 11417 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.